Variant report
Variant | esv3506084 |
---|---|
Chromosome Location | chr3:142609712-142613910 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:61)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:142609712-142609819 | HepG2 | liver: | n/a | chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739 |
2 | CEBPB | chr3:142609598-142609811 | K562 | blood: | n/a | chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739 |
3 | CEBPB | chr3:142613503-142613739 | K562 | blood: | n/a | n/a |
4 | EBF1 | chr3:142610126-142610469 | GM12878 | blood: | n/a | n/a |
5 | EP300 | chr3:142611828-142612102 | SK-N-SH_RA | brain: | n/a | n/a |
6 | EP300 | chr3:142611745-142612101 | SK-N-SH_RA | brain: | n/a | n/a |
7 | GATA2 | chr3:142611753-142612097 | SH-SY5Y | brain: | n/a | n/a |
8 | GATA3 | chr3:142611563-142612252 | SK-N-SH | brain: | n/a | n/a |
9 | GATA3 | chr3:142611731-142612124 | T-47D | breast: | n/a | n/a |
10 | GATA3 | chr3:142611638-142612287 | SK-N-SH | brain: | n/a | n/a |
11 | GATA3 | chr3:142611840-142612002 | SH-SY5Y | brain: | n/a | n/a |
12 | MYC | chr3:142612708-142612792 | MCF-7 | breast: | n/a | n/a |
13 | NFYB | chr3:142611546-142611907 | K562 | blood: | n/a | n/a |
14 | NFYB | chr3:142613511-142613762 | GM12878 | blood: | n/a | chr3:142613576-142613590 |
15 | NFYB | chr3:142613405-142613850 | K562 | blood: | n/a | chr3:142613576-142613590 |
16 | NFYB | chr3:142611554-142611832 | Hela-S3 | cervix: | n/a | n/a |
17 | PBX3 | chr3:142611627-142612074 | SK-N-SH | brain: | n/a | n/a |
18 | POLR2A | chr3:142609360-142609770 | SK-N-MC | brain: | n/a | n/a |
19 | POLR2A | chr3:142611500-142611640 | GM12878 | blood: | n/a | n/a |
20 | POLR2A | chr3:142611797-142611858 | ProgFib | skin: | n/a | n/a |
21 | POLR2A | chr3:142611650-142611651 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr3:142611677-142611710 | GM12878 | blood: | n/a | n/a |
23 | USF1 | chr3:142613441-142613646 | SK-N-SH_RA | brain: | n/a | chr3:142613560-142613571 |
24 | USF1 | chr3:142613326-142613844 | HCT-116 | colon: | n/a | chr3:142613560-142613571 |
25 | USF1 | chr3:142613398-142613687 | SK-N-SH_RA | brain: | n/a | chr3:142613560-142613571 |
26 | USF1 | chr3:142613398-142613712 | A549 | lung: | n/a | chr3:142613560-142613571 |
27 | USF1 | chr3:142613460-142613659 | HepG2 | liver: | n/a | chr3:142613560-142613571 |
28 | USF1 | chr3:142613372-142613786 | H1-hESC | embryonic stem cell: | n/a | chr3:142613560-142613571 |
29 | USF1 | chr3:142611654-142611874 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | USF1 | chr3:142613433-142613755 | ECC-1 | luminal epithelium: | n/a | chr3:142613560-142613571 |
31 | USF1 | chr3:142613365-142613651 | A549 | lung: | n/a | chr3:142613560-142613571 |
32 | USF1 | chr3:142613445-142613772 | H1-hESC | embryonic stem cell: | n/a | chr3:142613560-142613571 |
33 | USF1 | chr3:142611597-142611916 | SK-N-SH_RA | brain: | n/a | n/a |
34 | USF1 | chr3:142613362-142613766 | ECC-1 | luminal epithelium: | n/a | chr3:142613560-142613571 |
35 | USF1 | chr3:142611528-142611947 | K562 | blood: | n/a | n/a |
36 | USF1 | chr3:142611585-142611832 | A549 | lung: | n/a | n/a |
37 | USF1 | chr3:142613421-142613667 | HepG2 | liver: | n/a | chr3:142613560-142613571 |
38 | USF1 | chr3:142611546-142611967 | SK-N-SH | brain: | n/a | n/a |
39 | USF1 | chr3:142611608-142611853 | SK-N-SH_RA | brain: | n/a | n/a |
40 | USF1 | chr3:142613334-142613743 | K562 | blood: | n/a | chr3:142613560-142613571 |
41 | USF1 | chr3:142613392-142613713 | K562 | blood: | n/a | chr3:142613560-142613571 |
42 | USF1 | chr3:142611597-142611891 | HCT-116 | colon: | n/a | n/a |
43 | USF2 | chr3:142613528-142613621 | Hela-S3 | cervix: | n/a | chr3:142613560-142613571 |
44 | USF2 | chr3:142613451-142613708 | HepG2 | liver: | n/a | chr3:142613560-142613571 |
45 | USF2 | chr3:142611638-142611921 | Hela-S3 | cervix: | n/a | chr3:142611753-142611764 |
46 | USF2 | chr3:142613429-142613683 | H1-hESC | embryonic stem cell: | n/a | chr3:142613560-142613571 |
47 | USF2 | chr3:142613437-142613666 | K562 | blood: | n/a | chr3:142613560-142613571 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:142610864-142610914 | HPAEpiC | pulmonary alveolar: | n/a |
2 | chr3:142610864-142610914 | HNPCEpiC | eye: | n/a |
3 | chr3:142610864-142610914 | T-47D | breast: | n/a |
4 | chr3:142610864-142610914 | IMR90 | lung: | fetal |
5 | chr3:142610864-142610914 | HL-60 | blood: | n/a |
6 | chr3:142610864-142610914 | HepG2 | liver: | n/a |
7 | chr3:142610864-142610914 | HCPEpiC | choroid plexus: | n/a |
8 | chr3:142610864-142610914 | MCF10A-Er-Src | breast: | n/a |
9 | chr3:142610864-142610914 | A549 | lung: | n/a |
10 | chr3:142610864-142610914 | K562 | blood: | n/a |
11 | chr3:142610864-142610914 | HAEpiC | amniotic membrane: | n/a |
12 | chr3:142610864-142610914 | AoSMC | blood vessel: | n/a |
13 | chr3:142610864-142610914 | AG04450 | lung: | fetal |
14 | chr3:142610864-142610914 | HRPEpiC | eye: | n/a |
15 | chr3:142610864-142610914 | GM12878 | blood: | n/a |
16 | chr3:142610864-142610914 | ProgFib | skin: | n/a |
17 | chr3:142610864-142610914 | Hepatocyte | liver: | n/a |
18 | chr3:142610864-142610914 | NHBE | bronchial: | n/a |
19 | chr3:142610864-142610914 | SK-N-SH_RA | brain: | n/a |
20 | chr3:142610864-142610914 | HCT-116 | colon: | n/a |
21 | chr3:142610864-142610914 | PFSK-1 | brain: | n/a |
22 | chr3:142610864-142610914 | HRE | kidney: | n/a |
23 | chr3:142610864-142610914 | AG10803 | skin: | n/a |
24 | chr3:142610864-142610914 | AG09309 | skin: | n/a |
25 | chr3:142610864-142610914 | HCF | heart: | n/a |
26 | chr3:142610864-142610914 | H1-hESC | embryonic stem cell: | embryo |
27 | chr3:142610864-142610914 | Hela-S3 | cervix: | n/a |
28 | chr3:142610864-142610914 | HEEpiC | esophagus: | n/a |
29 | chr3:142610864-142610914 | BJ | skin: | n/a |
30 | chr3:142610864-142610914 | NH-A | brain: | n/a |
31 | chr3:142610864-142610914 | NHDF-neo | bronchial: | n/a |
32 | chr3:142610864-142610914 | SK-N-SH | brain: | n/a |
33 | chr3:142610864-142610914 | GM06990 | blood: | n/a |
34 | chr3:142610864-142610914 | AG09319 | gingival: | n/a |
35 | chr3:142610864-142610914 | Jurkat | blood: | n/a |
36 | chr3:142610864-142610914 | SAEC | small airway: | n/a |
37 | chr3:142610864-142610914 | RPTEC | kidney: | n/a |
38 | chr3:142610864-142610914 | NB4 | blood: | n/a |
39 | chr3:142610864-142610914 | AG04449 | skin: | fetal |
40 | chr3:142610864-142610914 | HMEC | breast: | n/a |
41 | chr3:142610864-142610914 | PrEC | prostate: | n/a |
42 | chr3:142610864-142610914 | HCM | heart: | n/a |
43 | chr3:142610864-142610914 | Caco-2 | colon: | n/a |
44 | chr3:142610864-142610914 | SKMC | muscle: | n/a |
45 | chr3:142610864-142610914 | HEK293 | kidney: | embryo |
46 | chr3:142610864-142610914 | LNCaP | prostate: | n/a |
47 | chr3:142610864-142610914 | SK-N-MC | brain: | n/a |
48 | chr3:142610864-142610914 | HRCEpiC | kidney: | n/a |
49 | chr3:142610864-142610914 | BE2_C | brain: | n/a |
50 | chr3:142610864-142610914 | NT2-D1 | testis: | n/a |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:142611367..142612951-chr3:142614638..142616165,2 | MCF-7 | breast: | |
2 | chr3:142613521..142615754-chr3:142620913..142622791,2 | K562 | blood: | |
3 | chr3:142612125..142613700-chr3:142616630..142618763,2 | K562 | blood: | |
4 | chr3:142606798..142610492-chr3:142610655..142614860,4 | K562 | blood: | |
5 | chr3:142296468..142299283-chr3:142609997..142611852,2 | MCF-7 | breast: | |
6 | chr3:142606684..142610842-chr3:142612134..142615334,5 | MCF-7 | breast: | |
7 | chr3:142609483..142612071-chr3:142616369..142619084,2 | K562 | blood: | |
8 | chr3:142598080..142600621-chr3:142609257..142610987,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PCOLCE2 | TF binding region |
PCOLCE2 | CpG island |
ENSG00000175054 | chromatin interactions |
ENSG00000163710 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73864499 | chr3:142609729-142609730 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs575774260 | chr3:142609731-142609732 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs139777863 | chr3:142609753-142609754 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs555136725 | chr3:142609759-142609760 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs3755734 | chr3:142609767-142609768 | Weak transcription Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs186220175 | chr3:142609807-142609808 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs144524042 | chr3:142609837-142609838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552982864 | chr3:142609858-142609859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4683434 | chr3:142609913-142609914 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs369020205 | chr3:142610044-142610045 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs571439630 | chr3:142610085-142610086 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs528238307 | chr3:142610118-142610119 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs546183182 | chr3:142610126-142610127 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs544977054 | chr3:142610157-142610158 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs563469896 | chr3:142610208-142610209 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs114723150 | chr3:142610239-142610240 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs190724503 | chr3:142610290-142610291 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs558474481 | chr3:142610293-142610294 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs532271340 | chr3:142610316-142610317 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs146656542 | chr3:142610356-142610357 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs528071402 | chr3:142610358-142610359 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs139096746 | chr3:142610361-142610362 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs149893665 | chr3:142610409-142610410 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs532816392 | chr3:142610412-142610413 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs551008265 | chr3:142610419-142610420 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs569420486 | chr3:142610423-142610424 | Weak transcription Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs112345129 | chr3:142610487-142610488 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs555099576 | chr3:142610522-142610523 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs567011673 | chr3:142610528-142610529 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs144968662 | chr3:142610543-142610544 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs6778966 | chr3:142610610-142610611 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs113748740 | chr3:142610643-142610644 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs149084292 | chr3:142610647-142610648 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs56237202 | chr3:142610663-142610664 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs56389497 | chr3:142610671-142610672 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs557007014 | chr3:142610684-142610685 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs575071355 | chr3:142610706-142610707 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs143144756 | chr3:142610726-142610727 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs373151539 | chr3:142610754-142610755 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs2707974 | chr3:142610797-142610798 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs182865641 | chr3:142610812-142610813 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs147846969 | chr3:142610843-142610844 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs73234726 | chr3:142610864-142610865 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs187932235 | chr3:142610865-142610866 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs191023424 | chr3:142610886-142610887 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs551235758 | chr3:142610898-142610899 | Weak transcription Enhancers | CpG islandChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs73234727 | chr3:142610920-142610921 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs530309510 | chr3:142610941-142610942 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs116161109 | chr3:142610944-142610945 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs141405559 | chr3:142610952-142610953 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 21129771 | CNVD |
Ovarian cancer | 23621864 | CNVD |
Breast cancer | 21364760 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:142608200-142610600 | Weak transcription | K562 | blood |
2 | chr3:142608400-142615200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr3:142608600-142615200 | Weak transcription | Hela-S3 | cervix |
4 | chr3:142608600-142615400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr3:142608600-142617800 | Weak transcription | Aorta | Aorta |
6 | chr3:142609200-142609800 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr3:142609600-142613400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr3:142609600-142616800 | Weak transcription | Adipose Nuclei | Adipose |
9 | chr3:142609800-142610000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr3:142610000-142610200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr3:142610000-142615200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr3:142610400-142610600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr3:142610600-142611800 | Enhancers | K562 | blood |
14 | chr3:142611800-142613400 | Weak transcription | K562 | blood |
15 | chr3:142613400-142613600 | Enhancers | K562 | blood |
16 | chr3:142613400-142613800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr3:142613800-142615200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |